VIEWS AND REVIEWS DIFFUSE ADENOMYOSIS PRIOR TO FROZEN EMBRYO TRANSFER: CLINICAL RELEVANCE, DIAGNOSIS AND TREATMENT

Review OA: closed CC0
View on OpenAlex View on PubMed View at publisher

Abstract

Adenomyosis has evolved from a rare histopathological curiosity, first described in hysterectomy specimens in the nineteenth century, into a condition now commonly recognized in reproductive-aged women undergoing assisted reproductive technology. This transition largely reflects the widespread adoption of high-resolution transvaginal ultrasound and magnetic resonance imaging, which have made it possible to identify the disease well before the stage of overt symptoms or surgical specimens. As a result, diffuse adenomyosis, once regarded as a symptomatic disease of older, parous women, is now frequently found as a clinically silent condition in young, nulliparous patients presenting for fertility care. This growing recognition has clinical importance because adenomyosis is consistently associated with poorer reproductive outcomes after in vitro fertilization, including lower pregnancy and live birth rates and a higher risk of miscarriage, with the strength of this association tied to disease severity and phenotype rather than to its mere presence. These observations provide the biological rationale for optimizing the uterine environment before frozen embryo transfer (FET), an approach made feasible by the ability to separate embryo availability from the timing of transfer. A range of hormonal, medical, and surgical strategies have been proposed for this purpose, though current evidence does not yet support a single, universal pretreatment approach. This manuscript reviews the historical background, contemporary epidemiology, and clinical impact of diffuse adenomyosis in assisted reproduction outcome and introduces a planned series of subsequent manuscripts addressing its pathophysiology, diagnosis, and medical and surgical management prior to FET in greater depth.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-11-21T06:17:04.340742+00:00
openalex
last seen: 2026-11-21T06:07:56.064915+00:00
pubmed
last seen: 2026-11-21T06:09:43.705417+00:00
License: CC0 · commercial use OK